Home | Welcome to Contract Pharma   
Last Updated Thursday, May 28 2015

Print RSS Feed

Search Results for 'Preclinical'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

Published May 21, 2015
The company has invested €2 million in latest-generation technology to expand its R&D and quality control services Read More »
Published May 19, 2015
Will evaluate combinations of Advaxis’s Lm-LLO immunotherapy technology and Sorrento’s immunomodulatory antibodies Read More »
Published May 14, 2015
(Irvine, CA) (Job Number: 151010) Read More »
Published May 14, 2015
Catalent to provide biomanufacturing activities for MANF protein Read More »
Published May 12, 2015
Will support commercial-scale ADC manufacturing Read More »
Published May 8, 2015
From preclinical development to commercial supply, Patheon leads the industry in the development and manufacture of mammalian cell culture drug substances. We give biotech companies the ability to pursue opportunities around the globe with a fully in… Read More »
Published May 8, 2015
With an expert team and fully integrated specialized scientific resources already in place, Patheon was able to take this high-potency small-molecule drug candidate from preclinical development all the way to commercial launch in less than five years… Read More »
Published May 6, 2015
Gains portfolio of histone demethylases for the treatment of certain cancers Read More »
CRO Outlook & Drug Development Trends
By Kristin Brooks , Contract Pharma
Published May 6, 2015
CRO industry grows as increasingly complex R&D trends demand advanced expertise Read More »
Published April 20, 2015
Will evaluate birinapant in combination with KEYTRUDA in solid tumors Read More »
Published April 17, 2015
Samcyprone used for the treatment of malignant melanoma stage IIb to IV Read More »
Published April 17, 2015
Takeover expands Sartorius’ service portfolio Read More »
Published April 15, 2015
Will provide discovery and development services from gene to candidates and beyond Read More »
Published April 9, 2015
Will provide Japanese
 clinical development services Read More »
Published April 7, 2015
Enter into license agreement on novel small molecules targeting mTORC1 activation Read More »
Published April 7, 2015
Combined company to develop and market new services for pharmaceutical R&D Read More »
Published April 6, 2015
Aims to optimize two of Pfizer’s targeted oncology drugs Read More »
Biosimilars Improving Efficiency, Cost for All Biologics
By Eric S. Langer and Ronald A. Rader, BioPlan Associates
Published April 1, 2015
Now that the FDA has just approved its first product under biosimilar regulations—Zarxio—containing filgrastim (G-CSF), a biosimilar version of Neupogen from Amgen, we can expect some more rapid shifts in the market. Factors like how this… Read More »
Preclinical Evaluation of Auto-disable (AD) Intradermal (ID) Adapter
By Dr. Izzy Tsals , SID Technologies
Published April 1, 2015
ADID found to increase accuracy and prevent reuse Read More »
Published March 30, 2015
Will install a new Class 100,000 suite at its North East England facility Read More »
Published March 19, 2015
To develop and commercialize Hanmi's oral BTK inhibitor Read More »
Published March 18, 2015
Downing to lead drug discovery and early-stage development efforts Read More »
Published March 17, 2015
Collaboration will evaluate the combination of varlilumab and MPDL3280A Read More »
Published March 16, 2015
Wallace brings 20 years of business development experience Read More »
Published March 16, 2015
To discover and develop anti-cancer immunotherapies Read More »
Published March 13, 2015
First and only clinical trial to reduce hippocampal overactivity during aMCI, the pre-dementia stage of Alzheimer’s disease Read More »
Published March 6, 2015
CoE in San Diego has 46,000 sq.-ft. of lab, office and sample storage space Read More »
Consolidation in Outsourcing
By Michael A. Martorelli , Director, Fairmount Partners
Published March 6, 2015
Reviewing 2014’s M&A activity Read More »
Published March 5, 2015
To provide integrated offering for candidate selection through to early stage trials Read More »
Published March 5, 2015
Includes patents, three preclinical candidates and related assets Read More »
Published February 24, 2015
Forms two business units: Contract Research Services and Research Models and Services Read More »
Published February 24, 2015
Will manufacture AB-022 for the treatment of cardiovascular diseases Read More »
Published February 23, 2015
Merck to purchase 15% equity stake in NGM Read More »
Published February 23, 2015
Namchuk responsible for advancing the early-stage product pipeline Read More »
Published February 23, 2015
Expands immuno-oncology pipeline Read More »
Published February 17, 2015
Labguru platform tracks projects, protocols, biologic collections and materials Read More »
Published February 12, 2015
Jayaraman and Kemmerling take on Discovery and Preclinical roles Read More »
Published February 2, 2015
To provide upstream process development from single-use biodevelopment center in France Read More »
Using Technology to Improve Study Startup
By Roshan Padbidri and Maria Breaux , goBalto Singapore and goBalto San Francisco
Published January 29, 2015
A necessary step that provides companies with a competitive advantage. Read More »
Jump Starting the Non-Profit Research Engine
By Kate Hilyard , Managing Director, BioFocus
Published January 29, 2015
How CROs are teaming up with disease foundations to accelerate drug discovery. Read More »
What is Driving the Outsourcing Market?
By Divyaa Ravishankar, Senior Industry Analyst, Frost & Sullivan Life Sciences
Published January 29, 2015
CRO industry generates healthy partnerships through co-development of drugs, diagnostics and demand for functional services. Read More »
Published January 19, 2015
Will support development and manufacture of drug candidates for neurological disorders Read More »
Published January 14, 2015
Gaspar to lead Lisbon and New Jersey teams Read More »
Published January 13, 2015
Aims to discover and develop vaccines and treatments against viral diseases Read More »
Published January 12, 2015
Will include additional oncology targets Read More »
Published January 6, 2015
Sarecycline advances to Phase III trials Read More »
Published January 5, 2015
Aims to develop and commercialize next-gen (CAR) T cell immunotherapies Read More »
Published January 5, 2015
Aims to develop and commercialize small molecule anti-fibrotic therapies Read More »
Published January 5, 2015
Gains preclinical CMV vaccine candidate Read More »
Published December 22, 2014
GMP manufacture of TKM-Ebola-Guinea is complete and 100 treatment courses are available Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On